Differential expression of red cell proteins in hemoglobinopathy

Proteomics - Clinical Applications

Volumn 5, Issue 1-2, 2011, Pages 98-108

  Chakrabarti, Abhijit ^a   Bhattacharya, Dipankar ^a   Basu, Avik ^a   Basu, Sumanta ^a   Saha, Sutapa ^a   Halder, Suchismita ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

Chaperones; Erythrocyte; Hemoglobin variants; Redox enzymes; Thalassemia

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; CHAPERONE; HEMOGLOBIN E; HYDROXYUREA; PROTEOME; REGULATOR PROTEIN;

AMINO ACID SEQUENCE; BETA THALASSEMIA; CELL INTERACTION; CLINICAL FEATURE; CYTOSOL; DISEASE ASSOCIATION; DISEASE MARKER; DRUG MECHANISM; ERYTHROCYTE MEMBRANE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ASSOCIATION; HEMOGLOBINOPATHY; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN TARGETING; PROTEOMICS; REVIEW; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOGLOBINOPATHIES; HEMOGLOBINS, ABNORMAL; HUMANS; PROTEOME; THALASSEMIA;

EID: 79251546081     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000063     Document Type: Review

References (70)

1. Nguyen-Khuong, T., Fitzgerald, A., Zhao, Z., Willcox, M., Walsh, B. J., Improvements for the visualization of low-molecular weight protein and peptides of human tears using MALDI. Proteomics 2008, 8, 3424-3432.
2. Hoffman, R., Benz E. J., Shattil, S. J., Furie, B. et al. (Eds.), Plasma Membrane Dynamics and Organization. Churchill Livingstone, New York 2000.
3. Mohandas, N., Phillips, W. M., Bessis, M., Red blood cell deformability and hemolytic anemias. Semin. Hematol. 1979, 16, 95-114.
4. Chien, S., Red cell deformability and its relevance to blood flow. Annu. Rev. Physiol. 1987, 49, 177-192.
5. Datta, P., Chakrabarty, S. B., Chakrabarty, A., Chakrabarti, A., Interaction of erythroid spectrin with hemoglobin variants: implications in beta-thalassemia. Blood Cells Mol. Dis. 2003, 30, 248-253.
6. D'Alessandro, A., Righetti, P. G., Zolla, L., The red blood cell proteome and interactome: an update. J. Proteome Res. 2010, 9, 144-163.
7. Delaunay, J., The molecular basis of hereditary red cell membrane disorders. Blood Rev. 2007, 21, 1-20.
8. Walensky, L. D., Narla, M., Lux, S. E., IV, Blood: Principles and Practice of Hematology, Lippincott Williams & Wilkins, Philadelphia 2003.
9. Pasini, E. M., Kirkegaard, M., Mortensen, P., Lutz, H. U. et al., In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006, 108, 791-801.
10. Chasis, J. A., Mohandas, N., Red blood cell glycophorins. Blood 1992, 80, 1869-1879.
11. Mohandas, N., Evans, E., Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. Annu. Rev. Biophys. Biomol. Struct. 1994, 23, 787-818.
12. Arai, K., Iizuka, S., Makita, A., Oikawa, K., Taniguchi, N., Purification of Cu-Zn-superoxide dismutase from human erythrocytes by immunoaffinity chromatography: evidence for the presence of isoelectric heterogeneity. J. Immunol. Methods 1986, 91, 139-143.
13. Higashi, T., Shibata, Y., Yagi, M., Hirai, H., Purification and properties of rat erythrocyte catalase; comparison with rat liver catalase. J. Biochem. 1966, 59, 115-121.
14. Wood, Z. A., Schroder, E., Robin Harris, J., Poole, L. B., Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 2003, 28, 32-40.
15. + transport in erythrocyte membrane vesicles requires a cytoplasmic protein. J. Biol. Chem. 1991, 266, 18964-18968.
16. 2 levels in erythrocytes. Free Radic. Biol. Med. 2005, 39, 1407-1417.
17. Lee, T. H., Kim, S. U., Yu, S. L., Kim, S. H. et al., Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 2003, 101, 5033-5038.
18. Stuhlmeier, K. M., Kao, J. J., Wallbrandt, P., Lindberg, M. et al., Antioxidant protein 2 prevents methemoglobin formation in erythrocyte hemolysates. Eur. J. Biochem. 2003, 270, 334-341.
19. Low, F. M., Hampton, M. B., Peskin, A. V., Winterbourn, C. C., Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 2007, 109, 2611-2617.
20. Montel-Hagen, A., Sitbon, M., Taylor, N., Erythroid glucose transporters. Curr. Opin. Hematol. 2009, 16, 165-172.
21. Khan, A. A., Hanada, T., Mohseni, M., Jeong, J. J. et al., Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1. J. Biol. Chem. 2008, 283, 14600-14609.
22. Brown, R. S., Wahl, R. L., Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study. Cancer 1993, 72, 2979-2985.
23. Concha, I. I., Velasquez, F. V., Martinez, J. M., Angulo, C. et al., Human erythrocytes express GLUT5 and transport fructose. Blood 1997, 89, 4190-4195.
24. Patterson, S. T., Li, J., Kang, J. A., Wickrema, A. et al., Loss of specific chaperones involved in membrane glycoprotein biosynthesis during the maturation of human erythroid progenitor cells. J. Biol. Chem. 2009, 284, 14547-14557.
25. Kihm, A. J., Kong, Y., Hong, W., Russell, J. E. et al., An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature 2002, 417, 758-763.
26. Feng, L., Gell, D. A., Zhou, S., Gu, L. et al., Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin. Cell 2004, 119, 629-640.
27. Weiss, M. J., Zhou, S., Feng, L., Gell, D. A. et al., Role of alpha-hemoglobin-stabilizing protein in normal erythropoiesis and beta-thalassemia. Ann. N Y Acad. Sci. 2005, 1054, 103-117.
28. Nanney, M. S., Haire-Joshu, D., Elliott, M., Hessler, K., Brownson, R. C., Evaluating changeability to improve fruit and vegetable intake among school aged children. Nutr. J. 2005, 4, 34.
29. Edwards, J. J., Anderson, N. G., Nance, S. L., Anderson, N. L., Red cell proteins. I. Two-dimensional mapping of human erythrocyte lysate proteins. Blood 1979, 53, 1121-1132.
30. Golaz, O., Hughes, G. J., Frutiger, S., Paquet, N. et al., Plasma and red blood cell protein maps: update 1993. Electrophoresis 1993, 14, 1223-1231.
31. Low, T. Y., Seow, T. K., Chung, M. C., Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002, 2, 1229-1239.
32. Jiang, M., Jia, L., Jiang, W., Hu, X. et al., Protein disregulation in red blood cell membranes of type 2 diabetic patients. Biochem. Biophys. Res. Commun. 2003, 309, 196-200.
33. Caterino, M., Ruoppolo, M., Orru, S., Savoia, M. et al., Characterization of red cell membrane proteins as a function of red cell density: annexin VII in different forms of hereditary spherocytosis. FEBS Lett. 2006, 580, 6527-6532.
34. Biondani, A., Turrini, F., Carta, F. et al., Heat-shock protein-27, -70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidence from transgenic sickle cell mouse model. Proteomics Clin. Appl. 2008, 2, 206-719.
35. Ghatpande, S. S., Choudhary, P. K., Quinn, C. T., Goodman, S. R., Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome. Exp. Biol. Med. 2008, 233, 1510-1517.
36. Kakhniashvili, D. G., Griko, N. B., Bulla, L. A., Jr., et al., The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp. Biol. Med. 2005, 230, 787-792.
37. Florens, L., Liu, X., Wang, Y., Yang, S. et al., Proteomics approach reveals novel proteins on the surface of malaria-infected erythrocytes. Mol. Biochem. Parasitol. 2004, 135, 1-11.
38. Bosman, G. J., Lasonder, E., Luten, M., Roerdinkholder-Stoelwinder, B. et al., The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008, 48, 827-835.
39. D'Amici, G. M., Rinalducci, S., Zolla, L., Proteomic analysis of RBC membrane protein degradation during blood storage. J. Proteome Res. 2007, 6, 3242-3255.
40. Ramstrom, M., Hagman, C., Mitchell, J. K., Derrick, P. J. et al., Depletion of high-abundant proteins in body fluids prior to liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 2005, 4, 410-416.
41. Prabakaran, S., Wengenroth, M., Lockstone, H. E., Lilley, K. et al., 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. J. Proteome Res. 2007, 6, 141-149.
42. Bhattacharya, D., Mukhopadhyay, D., Chakrabarti, A., Hemoglobin depletion from red blood cell cytosol reveals new proteins in 2-D gel-based proteomics study. Proteomics Clin. Appl. 2007, 1, 561-564.
43. Kakhniashvili, D. G., Bulla, L. A., Jr., Goodman, S. R., The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol. Cell Proteomics 2004, 3, 501-509.
44. Tyan, Y. C., Jong, S. B., Liao, J. D., Liao, P. C. et al., Proteomic profiling of erythrocyte proteins by proteolytic digestion chip and identification using two-dimensional electrospray ionization tandem mass spectrometry. J. Proteome Res. 2005, 4, 748-757.
45. Ringrose, J. H., van Solinge, W. W., Mohammed, S., O'Flaherty, M. C. et al., Highly efficient depletion strategy for the two most abundant erythrocyte soluble proteins improves proteome coverage dramatically. J. Proteome Res. 2008, 7, 3060-3063.
46. Roux-Dalvai, F., Gonzalez de Peredo, A., Simo, C., Guerrier, L. et al., Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol. Cell Proteomics 2008, 7, 2254-2269.
47. Thulasiraman, V., Lin, S., Gheorghiu, L., Lathrop, J. et al., Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 2005, 26, 3561-3571.
48. Chaurasia, G., Iqbal, Y., Hanig, C., Herzel, H. et al., UniHI: an entry gate to the human protein interactome. Nucleic Acids Res. 2007, 35, D590-D594.
49. Goodman, S. R., Kurdia, A., Ammann, L., Kakhniashvili, D., Daescu, O., The human red blood cell proteome and interactome. Exp. Biol. Med. 2007, 232, 1391-1408.
50. Weatherall, D., Beginnings: the molecular pathology of hemoglobin, in: Provan, D., Gribben, J. G. (Eds.), Molecular Hematology, 3rd Edn, Chapter 1, Wiley-Blackwell, Oxford, UK 2010.
51. Flint, J., Harding, R. M., Clegg, J. B., Boyce, A. J., Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Hum. Genet. 1993, 91, 91-117.
52. Flint, J., Harding, R. M., Boyce, A. J., Clegg, J. B., in: Redgers, G. P. (Ed.), Baillière's Clinical Haematology; Sickle cell Disease and Thalassaemia, Baillière Tindall and W. B. Saunders, London 1998.
53. Bain, B. J., Haemoglobinopathy Diagnosis, Blackwell Publishing, Oxford, UK, 2006, pp. 63-138.
54. Dickerson, R. E., Hemoglobin: Structure, Function, Evolution and Pathology, The Benjamin/Cummings Publishing Company, San Francisco, USA, 1983, pp. 118-164.
55. Voet, D., Voet, J. G., Biochemistry, Wiley, New York 1995, pp. 215-220.
56. Weatherall, D. J., Clegg, J. B., Thalassemia-a global public health problem. Nat. Med. 1996, 2, 847-849.
57. Yuthavong, Y., Ruenwongsa, P., Benyajati, C., Suttimool, W., Studies on the structural stability of haemoglobin E. J. Med. Assoc. Thailand 1975, 58, 351-356.
58. Ali, M. A., Quinlan, A., Wong, S. C., Identification of hemoglobin E by the isopropanol solubility test. Clin. Biochem. 1980, 13, 146-148.
59. Weatherall, D. J., Clegg, J. B., The Thalassaemia Syndrome, Blackwell Science, Oxford, UK 2001.
60. Traeger, J., Wood, W. G., Clegg, J. B., Weatherall, D. J., Defective synthesis of HbE is due to reduced levels of beta E mRNA. Nature 1980, 288, 497-499.
61. Lachant, N. A., Tanaka, K. R., Dapsone-associated Heinz body hemolytic anemia in a Cambodian woman with hemoglobin E trait. Am. J. Med. Sci. 1987, 294, 364-368.
62. Rees, D. C., Duley, J., Simmonds, H. A., Wonke, B. et al., Interaction of hemoglobin E and pyrimidine 5' nucleotidase deficiency. Blood 1996, 88, 2761-2767.
63. Ingram, V. M., A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 1956, 178, 792-794.
64. Shinar, E., Shalev, O., Rachmilewitz, E. A., Schrier, S. L., Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood 1987, 70, 158-164.
65. Schrier, S. L., Mohandas, N., Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties. Blood 1992, 79, 1586-1592.
66. Rees, D. C., Clegg, J. B., Weatherall, D. J., Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia? Blood 1998, 92, 2141-2146.
67. Bhattacharya, D., Saha, S., Basu, S., Chakravarty, S. et al., Differential regulation of redox proteins and chaperones in HbEβ-thalassemia erythrocyte proteome. Proteomics Clin. Appl. 2010, 4, 480-488.
68. Basu, S., Banerjee, D., Chandra, S., Chakrabarti, A., Loss of phospholipid membrane asymmetry and sialylated glycoconjugates from erythrocyte surface in haemoglobin E β-thalassaemia. Br. J. Haematol. 2008, 141, 92-99.
69. Chou, J., Choudhary, P. K., Goodman, S. R., Protein profiling of sickle cell versus control RBC core membrane skeletons by ICAT technology and tandem mass spectrometry. Cell Mol. Biol. Lett. 2006, 11, 326-337.
70. Ghatpande, S. S., Choudhary, P. K., Quinn, C. T., Goodman, S. R., In vivo pharmaco-proteomic analysis of hydroxyurea induced changes in the sickle red blood cell membrane proteome. J. Proteomics 2010, 73, 619-626.